Anti-CD20 versus Dimethyl Fumarate as First-Line Treatment for Pediatric Multiple Sclerosis: A Retrospective Cohort Study
Year: 2025
Type: article
Study design: Observational Study
Source: Neuropediatrics
DOI: 10.1055/a-2683-1150
Authors: Masoud Etemadifar, Aryana Ramezani, Pantea Miralaei, Nahad Sedaghat, Amir M. Jozaie, Mehrzad Ghorbani, Mehri Salari, Hasan Kaveyee
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413140456